Effect of oral contraceptive progestins on serum copper concentration

European Journal of Clinical Nutrition

Volumn 52, Issue 10, 1998, Pages 711-715

  Berg, G ^a   Kohlmeier, L ^b   Brenner, H ^a  

^a UNIVERSITY OF ULM   (Germany)

^b IL   (United States)

Author keywords

Cardiovascular disease; Copper; Oral contraceptives; Progestin

Indexed keywords

COPPER ION; DESOGESTREL; ETHINYLESTRADIOL PLUS LYNESTRENOL; GESTAGEN; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT;

ADULT; ANAMNESIS; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; COPPER BLOOD LEVEL; FEMALE; GERMAN FEDERAL REPUBLIC; HEALTH SURVEY; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MORTALITY; MULTIPLE REGRESSION; NUTRITION; ORAL DRUG ADMINISTRATION; QUESTIONNAIRE; THROMBOSIS;

EID: 0031720656     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1600631     Document Type: Article

References (38)

1. Belsley DA, Kuh E & Welsch RE (1980): Regression Diagnostics: Identifying Influential Data and Sources of Collinearity. New York: John Wiley & Sons.
2. Crews MG, Taper LJ & Ritchey SJ (1980): Effects of oral contraceptive agents on copper and zinc balance in young women. Am. J. Clin. Nutr. 33, 1940-1945.
3. Erkkola R, Hirvonen E, Luikiu J, Lumme R, Mannikko H & Aydinlik, S (1990): Ovulation inhibitors containing cyproterone acetate or desogestrel in the treatment of hyperandrogenic symptoms. Acta. Obstet. Gynecol. Scand. 69, 61-65.
4. Farmer RDT, Lawrenson RA, Thopson CR, Kennedy JG & Hambleton IR (1997): Population based study of risk of oral thromboembolism associated with various oral contraceptives. Lancet 349, 83-88.
5. Fischer PWF & L'Abbe MR (1990): Effects of age smoking, drinking, exercise and estrogen use on indices of copper status in healthy adults. Nutr. Res. 10, 1081-90.
6. Grandejan P, Nielsen GD, Jorgensen PJ & Horder M (1992): Reference intervals for trace elements in blood: significance for risk factors. Scand. J Clin. Lab. Invest. 52, 321-337.
7. Hinks LJ, Clayton BE & Lloyd RS (1983): Zinc and copper concentration in leucocytes and erythrocytes in healthy adults and the effect of oral contraceptives. J. Clin. Pathol. 36, 1016-1021.
8. Heese H, Lawrence MA, Dempster WS & Pocock F (1987): Reference values for serum copper, ceruloplasmin and zinc and haematological indices for healthy nulliparous women. S. Afr. Med. J. 72, 490-493.
9. Horwitt MK, Harvey CC & Dahm CH (1975): Relationship between levels of blood lipids, vitamins C, A, and E, serum copper compounds, and urinary excretions of tryptophan metabolites in women taking oral contraceptive therapy. Am. J. Clin. Nutr. 28, 403.
10. Jick H, Jick SS, Gurewich V, Myers MW & Vasilakis C (1995): Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 346, 1589-1593.
11. Johnson PE, Milne DB & Lykken GI (1992): Effects of age and sex on copper absorption, biological half-life, and status in humans. Am. J. Clin. Nutr. 56, 917-925.
12. Klevley LM, Inman L, Johnson LAK, Lawler M, Mahalko JR, Milne DB, Lukaski HC, Bolonchuk W & Sandstead HH (1984): Increased cholesterol in plasma in a young man during experimental copper depletion. Metabolism 33, 1112-1118.
13. Klevley LM (1989): Ischemic heart disease as copper deficiency. Adv. Exp. Med. Biol. 258, 197-208.
14. Kok FJ, van Duijn CM, Hofman A, Voet GB, Wolff FA, Paays CH & Valkenburg HA (1988): Serum copper and zinc and the risk of death from cancer and cardiovascular disease. Am. J. Epidemiol. 128, 352-359.
15. La Vecchia C (1991): Review, Sex hormones and cardiovascular risk. Human Reprod. 7, 162-166.
16. Liukko P, Erkkola R & Berginkk E W (1988): Progestagen-dependent effect on some plasma proteins during oral contraception. Gynecol. Obstet. Invest. 25, 118-122.
17. Lukaski HC (1989): Effects of exercise training on human copper and zinc nutriture. Adv. Exp. Med. Biol. 258, 163-170.
18. Margen S & King JC (1975): Effect of oral contraceptive agents on the metabolism of some trace minerals. Am. J. Clin. Nutr. 28, 392-400.
19. Milne DB & Johnson PE (1993): Assessment of copper status, effect of age gender on reference range in health adults. Clin. Chem. 39, 4883-4887.
20. Murad F & Kuret JA (1991): Estrogens and Progestins 1384-412. In: The Pharmacological Basis of Therapeutics eds. Eighth Edn, A Goodman Gilman, TW Rall AS Nies & P Taylor. New York: Pergamon Press.
21. Newhouse IJ, Clement DB & Lai C (1993): Effects of iron supplementation and discontinuation on serum copper, zinc, calcium, and magnesium levels in women. Med. Sci. Sports Exerc. 25, 562-571.
22. O'Leary JA & Spellacy W (1969): Zinc and copper levels in pregnant women and those taking oral contraceptives. J. Obstet. Gynecol 103, 131-132.
23. Prasad AS, Oberleas D, Lei KY, Moghissi KS & Stryker JC (1975): Effect of oral contraceptive agents on nutrients: I. Minerals. Am. J. Clin. Nutr. 28, 377-384.
24. Prema K, Ramalakshimi BA & Babu S (1980): Serum copper and zinc in hormonal contraceptive users. Fertil. Steril. 33, 267-271.
25. Realini JP & Goldzieher JW (1985): Oral contraceptives and cardiovascular disease: A critique of the epidemiologic studies. Am. J. Obstet. Gynecol 152, 729-798.
26. Reunanen A, Knekt P & Aaran RK (1992): Serum ceruloplasmin level and the risk of myocardial infarction and stroke. Am. J. Epidemiol. 136, 1082-1090.
27. Reunanen A, Knekt P, Marniemi J, Mäki J, Maatela J & Aromaa A (1996): Serum calcium, magnesium, copper and zinc and the risk of cardiovascular death. Eur. J. Clin. Nutr. 50, 431-437.
28. Salonen JT, Salonen R, Korpela H, Suntioinen S & Tuomilehto J (1991): Serum copper and the risk of acute myocardial infarction: a prospective population study in men in Eastern Finland. Am. J. Epidemiol. 134, 268-276.
29. Schneider A, Eberhardt W, Heseker H & Moch DKJ: (1992): Die VERA-Stichprobe im Vergleich mit Mikrozensus, Volkszählung und anderen Nationalen Untersuchungen. VERA-Schriftenreihe, Bd II, Kübler W, Anders HJ, Heeschen W (eds). Niederkleen (Germany): Wissenschaftlicher Fachverlag Dr. Fleck.
30. Si S, Jun-kang C, Mei-li H & Fortherby K (1989): Effect of some oral contraceptives on serum concentrations of sex hormone binding globuline and ceruloplasmin. Contraception 39, 385-399.
31. Siiteri PK (1987): Adipose tissue as source of hormones. Am. J. Clin. Nutr. 45, 277-282.
32. Sing EJ, Baccarini IM, O'Neill HJ & Olwin HJ (1978): Effects of oral contraceptives on zinc and copper levels in human plasma and endometrium during the menstrual cycle. Arch. Gynecol. 226, 303-306.
33. Speitling A, Hüppe R, Kohlmeier M, Matiaske B, Stelte W, Thefeld W & Wetzel S (1992): Methodical Handbook, Nutritional Survey and Risk Factors Analysis. VERA-Schriftenreihe, Bd Ib, Kübler W, Anders HJ, Heeschen W (eds). Niederkleen (Germany): Wissenschaftlicher Fachverlag Dr. Fleck.
34. Spitzer WO, Lewis MA, Heinemann LA, Thorogood M & MacRae K (1996): Third generation oral contraceptives and risk of venous thromboembolic disorders: An international case-control study. Br. Med. J. 312, 83-88.
35. Stauber JL & Florence TM (1988): A comperativ study of copper, lead, cadmium, and zinc in human sweat and blood. Sci. Tot. Environmental 74, 235-247.
36. Vir SC & Love AHG (1981): Zinc and copper nutriture of women taking oral contraceptive agents. Am. J. Clin. Nutr. 34, 1479-1483.
37. Willett W (1990): Nutritional Epidemiology. New York, Oxford: Oxford University Press.
38. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Concentration (1995): Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 346, 1582-1588.